IL-4-induced Stat6 activities affect apoptosis and gene expression in breast cancer cells

Cytokine

Volumn 42, Issue 1, 2008, Pages 39-47

  Zhang, Wen Jie ^a,b   Li, Ben Hui ^b   Yang, Xian Zi ^b   Li, Pin Dong ^b   Yuan, Qin ^b   Liu, Xiao Hong ^b   Xu, Shuang Bing ^b   Zhang, Yan ^b   Yuan, Jia ^b   Gerhard, Glenn S ^c   Masker, Kathryn K ^c   Dong, Cheng ^d   Koltun, Walter A ^e   Chorney, Michael J ^e  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

^c WEIS CENTER FOR RESEARCH   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Breast cancer; Expression microarray; IL 4; Stat6

Indexed keywords

CELL CYCLE PROTEIN; CYTOKINE; EGLN3 ENZYME; EOTAXIN 3; INTERLEUKIN 4; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN CISH; PROTEIN DUSP1; PROTEIN FOS; PROTEIN SIDTI; PROTEIN SOCSI; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-4; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR;

EID: 41149124798     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.01.016     Document Type: Article

References (30)

1. Ansel K.M., Djuretic I., Tanasa B., and Rao A. Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24 (2006) 607-656
2. Rothstein T.L. Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res 10 (2000) 245-266
3. Bruns H.A., and Kaplan M.H. The role of constitutively active Stat6 in leukemia and lymphoma. Crit Rev Oncol Hematol 57 (2006) 245-253
4. Simard J., and Jingras S. Crucial role of cytokines in sex steroid formation in normal and tumoral tissues. Mol Cell Endocrinol 171 (2001) 25-40
5. Levings M.K., and Schrader J.W. IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms. J Immunol 162 (1999) 5224-5229
6. Hebenstreit D., Wirnsberger G., Horejs-Hoeck J., and Duschl A. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev 17 (2006) 173-188
7. Hebenstreit D., Luft P., Schmiedlechner A., Regl G., Frischauf A.M., Aberger F., et al. IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the transcription initiation site. J Immunol 171 (2003) 5901-5907
8. Shimoda K., van Deursen J., Sangster M.Y., Sarawar S.R., Carson R.T., Tripp R.A., et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380 (1996) 630-633
9. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., et al. Essential role of Stat6 in IL-4 signalling. Nature 380 (1996) 627-630
10. Shirakawa I., Deichmann K.A., Izuhara I., Mao I., Adra C.N., and Hopkin J.M. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 21 (2000) 60-64
11. Ostrand-Rosenberg S., Grusby M.J., and Clements V.K. Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma. J Immunol 165 (2000) 6015-6019
12. Ostrand-Rosenberg S., Sinha P., Clements V., Dissanayake S.I., Miller S., Davis C., et al. Signal transducer and activator of transcription 6 (Stat6) and CD1: inhibitors of immunosurveillance against primary tumors and metastatic disease. Cancer Immunol Immunother 53 (2004) 86-91
13. Kacha A.K., Fallarino F., Markiewicz M.A., and Gajewski T.F. Cutting edge: spontaneous rejection of poorly immunogenic P1.HTR tumors by Stat6-deficient mice. J Immunol 165 (2000) 6024-6028
14. Ni Z., Lou W., Lee S.O., Dhir R., DeMiguel F., Grandis J.R., et al. Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. J Urol 167 (2002) 1859-1862
15. Qin J.Z., Kamarashev J., Zhang C.L., Dummer R., Burg G., and Dobbeling U. Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol 117 (2001) 583-589
16. Skinnider B.F., Elia A.J., Gascoyne R.D., Patterson B., Trumper L., Kapp U., et al. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99 (2002) 618-626
17. Guiter C., Dusanter-Fourt I., Copie-Bergman C., Boulland M.L., Le Gouvello S., Gaulard P., et al. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 104 (2004) 543-549
18. Zhang W.J., Koltun W.A., Tilberg A.F., Thompson J.F., and Chorney M.J. Genetic control of interleukin-4-induced activation of the human signal transducer and activator 6 signaling pathway. Hum Immunol 64 (2003) 402-415
19. Zhang W.J., Koltun W.A., Thompson J.F., Tilberg A.F., Galka E., Poritz L.S., et al. Human B lymphoblast cell lines defective of Stat6 signaling produce high levels of proinflammatory cytokines IL-12, TNFα and IFNγ. Int J Oncol 24 (2004) 447-454
20. null phenotype human lymphocytes exhibit increased apoptosis. J Surg Res 122 (2004) 14-20
21. Zhang M., Zhou Y., Xie C., Zhou F., Han G., and Zhang W.J. STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells. Cancer Lett 243 (2006) 38-46
22. Zhang W.J., Degli-Esposti M.A., Cobain T.J., Cameron P.U., Christiansen F.T., and Dawkins R.L. Differences in gene copy number carried by different MHC ancestral haplotypes: quantitation after physical separation of haplotypes by pulsed field gel electrophoresis. J Exp Med 171 (1990) 2101-2114
23. Hoeck J., and Woisetschlager M. Activation of eotaxin-3/CCL26 gene expression in human dermal fibroblasts is mediated by STAT6. J Immunol 167 (2001) 3216-3222
24. Chen Z., Lund R., Aittokallio T., Kosonen M., Nevalainen O., and Lahesmaa R. Identification of novel IL-4/Stat6-regulated genes in T lymphocytes. J Immunol 171 (2003) 3627-3635
25. Blanchard C., Durual S., Estienne M., Emami S., Vasseur S., and Cuber J.C. Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription. Int J Biochem Cell Biol 37 (2005) 2559-2573
26. Haque S.J., Harbor P.C., and Williams B.R. Identification of critical residues required for suppressor of cytokine signaling-specific regulation of interleukin-4 signaling. J Biol Chem 275 (2000) 26500-26506
27. Yoshimura A. Negative regulation of cytokine signaling. Clin Rev Allergy Immunol 28 (2005) 205-220
28. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., et al. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
29. Ohmori Y., Smith Jr. M.F., and Hamilton T.A. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol 157 (1996) 2058-2063
30. Li BH, Yang XZ, Li PD, Yuan Q, Liu XH, Yuan J, Zhang WJ. IL-4/Stat6 activities correlate with apoptosis and metastasis in colon cancer cells. Biochem Biophys Res Commun 2008. Available online: 21 February 2008.